CLAIM #11875 · Bristol-Myers Squibb Company (BMY) · 2023Q4 earnings call · Feb 2, 2024 · due Dec 31, 2025
“As it relates to IRA, we do expect an improvement in patient affordability as the patient out-of-pocket changes for patients this year and into next.”
Chris Boerner · CEO
PENDING
graded after results covering Dec 31, 2025 are reported
Verify independently
SEC filings for BMY ↗ · Claim quote is verbatim from the 2023Q4 earnings call.